In March 2025, the company introduced new strategies for just a direct-to-purchaser offering of its Wegovy weight loss drug. The company proven a whole new pharmacy, referred to as NovoCare, which might demand prospects $499 per 30 days for usage of the drug, below 50 percent the expense of the drug via other pharmaceutical distribution networks.[f